Anti-MUC1 scFv h(CD28-41BB-CD3ζ) CART, pCDCAR1

  • 1.00 Dollar US$
  • Published date: March 6, 2018
    • Shirley, New York, United States

https://www.creative-biolabs.com/car-t/pcdcar1-muc1-h-28bbζ-t-453.htm The vector of anti-MUC1 chimeric antigen receptor (CAR) is constructed for the engineering of T cells to target human MUC1. The T cells are genetically modified through transduction with a lentiviral vector expressing scFv of anti-MUC1 antibody linked to CD28 transmembrane domain/ endodomain and CD137 (4-1BB), CD3-zeta signaling domains. And the vector product was designed for the treatment of MUC1-expressing tumors .

Result 0 votes
Jerry Carter
1 votes

Useful information

  • Avoid scams by acting locally or paying with PayPal
  • Never pay with Western Union, Moneygram or other anonymous payment services
  • Don't buy or sell outside of your country. Don't accept cashier cheques from outside your country
  • This site is never involved in any transaction, and does not handle payments, shipping, guarantee transactions, provide escrow services, or offer "buyer protection" or "seller certification"

Related listings

  • Anti-CD79b (clone ch10D10)-Mc-MMAF ADC

    Anti-CD79b (clone ch10D10)-Mc-MMAF ADC

    Drug Development (United States ) September 25, 2020 Check with publisher

    This ADC product is comprised of an anti-CD79b monoclonal antibody (clone ch10D10) conjugated via a Mc linker to MMAF. The MMAF is targeted to hematopoietic tumors by immunerecognition and delivered into cancer cells via receptor mediated endocytosis...

  • Anti-CD79b (clone huMA79b.v28)-Mc-VC-PABC-MMAE ADC

    Anti-CD79b (clone huMA79b.v28)-Mc-VC-PABC-MMAE ADC

    Drug Development (United States ) September 25, 2020 Check with publisher

    This ADC product is comprised of an anti-CD79b monoclonal antibody (clone huMA79b.v18) conjugated via a Mc-VC-PABC linker to MMAE. The MMAE is targeted to hematopoietic tumors by immunerecognition and delivered into cancer cells via receptor mediated...

  • Anti-CD79b (clone huMA79b.v28)-BMPEO-DM1 ADC

    Anti-CD79b (clone huMA79b.v28)-BMPEO-DM1 ADC

    Drug Development (United States ) September 25, 2020 Check with publisher

    This ADC product is comprised of an anti-CD79b monoclonal antibody (clone huMA79b.v18) conjugated via a BMPEO linker to DM1. The DM1 is targeted to hematopoietic tumors by immunerecognition and delivered into cancer cells via receptor mediated endocy...